Publications
Specialty
Search
APP Institute Dermatology
08/17/2024
Jeffrey Cohen, MD, and Hannah Rodriguez, MPAS, PA-C, provided guidelines for choosing appropriate biologics based on associated comorbidities on the second day of the APP Institute Dermatology 2024.
APP Institute Dermatology
08/17/2024
During the second day of the APP Institute Dermatology 2024, David Rosmarin, MD, and Andrea Nguyen, DMSc, MPAS, PA-C, presented updates on advancing vitiligo care, focusing on targeted therapies and strategies to improve patient outcomes.
APP Institute Dermatology
08/17/2024
On the second day of the APP Institute Dermatology 2024, Andrea Nguyen, DMSc, MPAS, PA-C, and Candrice Heath, MD, FAAP, FAAD, discussed differentials, workups, and treatment options for scalp and hair disorders.
Vascular Disease Management
08/17/2024
During her Saturday presentation on DVA Day at AMP, Abigail Mize, BS, RDCS, RVT, from AMize Consulting Services LLC in Grand Rapids, Michigan, provided an overview of selecting patients for DVA based on imaging criteria.
APP Institute Dermatology
08/17/2024
Nnenna Agim, MD, and Peggy Vernon, RN, MA, CPNP, DCNP, FAANP, FSDNP, kicked off the second day of the APP Institute Dermatology 2024 with an in-depth overview of common and rare infectious diseases that affect pediatric patients.
Vascular Disease Management
08/16/2024
On Friday, George Pliagas, MD, FACS, FRCSC, from ACV Vascular in Las Vegas, Nevada, presented information about the Glidesheath Slender (Terumo) for tipiopedal access.
Vascular Disease Management
08/16/2024
In a presentation on Friday morning, Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (Clin Epi) spoke about the Efemoral Vascular Scaffold System, focusing on its innovative approach to treating femoropopliteal arterial occlusive disease.
APP Institute Dermatology
08/16/2024
At the inaugural APP Institute Dermatology 2024, experts delivered key insights into the management of rosacea, acne, cutaneous malignancies, and pruritus, offering practical updates for clinical practice.
APP Institute Dermatology
08/16/2024
During the final session on day one of the APP Institute Dermatology 2024, meeting co-chairs Lakshi Aldredge and Cynthia Trickett led a panel that reviewed appropriate patient management and the critical point of when to refer patients.
APP Institute Dermatology
08/16/2024
At the APP Institute Dermatology 2024, Matthew Zirwas, MD, and Douglas DiRuggiero, DMSc, MHS, PA-C, tackled the diagnosis and management of patients presenting with itch.
APP Institute Dermatology
08/16/2024
During the first day of the APP Institute Dermatology 2024, Ted Lain, MD, MBA, FAAD, and Martha Sikes, DMSc, RPh, PA-C, provided an extensive update on the management of cutaneous malignancies and field damage.
Oncology
08/16/2024
Prithviraj Bose, MD, discusses novel developments and future potential in myelofibrosis treatment, highlighting BET inhibitors, PIM kinase inhibitors, and phase 3 trial data on imetelstat, and luspatercept.
Oncology
08/16/2024
According to results from the TROPiCS-03 study, sacituzumab govitecan showed promising efficacy and manageable safety among patients with heavily pretreated advanced or metastatic endometrial cancer.
EMSWorld, Emergency & Mobile Medicine
08/16/2024
Strong leadership isn’t about having all the answers and getting everything right.
APP Institute Dermatology
08/16/2024
On the first day of the inaugural APP Institute Dermatology 2024, Hillary Baldwin, MD, and Heather Roebuck, DNP, FNP-BC, FAANP, discussed the evolving approach to managing rosacea and acne.
First Report Managed Care
08/16/2024
Current evidence regarding the role of brain-derived neurotrophic factor (BDNF) in patients with multiple sclerosis (MS) is largely inconclusive, according to a review article published in Frontiers in Neurology.
First Report Managed Care
08/16/2024
Compared with usual care, advice to use nasal spray at the first sign of a respiratory tract infection reduced the duration of respiratory infections, while nasal spray and a behavioral intervention promoting physical activity and stress reduction reduced antibiotic use. Researchers published their findings in The Lancet Behavioral Medicine.
Pharmacy Learning Network
08/16/2024
The National Community Pharmacists Association (NCPA) announced late July 2024 that it, along with dozens of providers from numerous states, had filed a class action lawsuit against UnitedHealth Group and its subsidiaries, Change Healthcare and Optum, due to a ransomware attack.
Psych Congress Network
08/16/2024
The US Food and Drug Administration (FDA) last week rejected the new drug application (NDA) from Lykos Therapeutics for midomafetamine (MDMA) capsules for the treatment of post-traumatic stress disorder (PTSD) in conjunction with psychotherapy.
EMSWorld
08/16/2024
EMS World has invited EMS leaders from the New York City Fire Department (FDNY) to share lessons learned from 9/11 through keynote remarks at the 2024 EMS World Expo.